These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16024609)

  • 1. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
    Zhou J; Hernandez G; Tu SW; Scholes J; Chen H; Tseng CP; Hsieh JT
    Cancer Res; 2005 Jul; 65(14):6089-96. PubMed ID: 16024609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V; Breuzard G; Fourré N; Dufer J
    Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y; Faria TN; Chambon P; Gudas LJ
    Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene.
    Maehara K; Uekawa N; Isobe K
    Biochem Biophys Res Commun; 2002 Jul; 295(1):187-92. PubMed ID: 12083788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of disabled-2 gene during megakaryocyte differentiation of k562 cells.
    Tseng CP; Huang CH; Tseng CC; Lin MH; Hsieh JT; Tseng CH
    Biochem Biophys Res Commun; 2001 Jul; 285(1):129-35. PubMed ID: 11437382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.
    Hoshino I; Matsubara H; Hanari N; Mori M; Nishimori T; Yoneyama Y; Akutsu Y; Sakata H; Matsushita K; Seki N; Ochiai T
    Clin Cancer Res; 2005 Nov; 11(21):7945-52. PubMed ID: 16278420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.
    Zhoul J; Hernandez G; Tu SW; Huang CL; Tseng CP; Hsieh JT
    Cancer Res; 2005 Nov; 65(21):9906-13. PubMed ID: 16267015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
    Zhang B; Laribee RN; Klemsz MJ; Roman A
    Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
    Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J
    Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
    Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
    Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors.
    Ellis DJ; Lawman ZK; Bonham K
    Biochem Biophys Res Commun; 2008 Mar; 367(3):656-62. PubMed ID: 18179771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of HDAC inhibitor-induced thrombocytopenia.
    Matsuoka H; Unami A; Fujimura T; Noto T; Takata Y; Yoshizawa K; Mori H; Aramori I; Mutoh S
    Eur J Pharmacol; 2007 Oct; 571(2-3):88-96. PubMed ID: 17628529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.